| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Donald A Denkhaus is Director at CPRX. Donald A Denkhaus's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Donald A Denkhaus has 19 Form 4 filings on record from September 2022 to December 2025, all as Director at Catalyst Pharmaceuticals (CPRX), 2022–2025.
The 24 reported transactions were 14 option exercises, 8 option or other derivative awards and 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $639K.
The largest open-market sale was 20,000 shares of CPRX at an average $16.59 on November 11, 2022, about $332K. Twelve months later CPRX was down 12%.